Literature DB >> 22076960

Frameless stereotactic targeting devices: technical features, targeting errors and clinical results.

Gerlig Widmann1, Peter Schullian, Martin Ortler, Reto Bale.   

Abstract

BACKGROUND: Brain biopsies (BB) and depth electrode placements (DEP) are increasingly performed using frameless stereotactic targeting devices. This paper is intended to provide a comprehensive review of the technical features, targeting errors and clinical results.
METHODS: A PubMed literature search from 1995-2010 was performed.
RESULTS: (A) Modified stereotactic arcs, (B) arm-based devices with and without aiming facilities, and (C) skull affixed devices were found. Guidance technologies were navigation systems (all groups), prospective stereotaxy and custom designed platforms (group C). Mean total errors ranged between 4.4 and 5.4 mm for BB and 2.0 and 3.2 mm for DEP. Diagnostic yield of BB was 89-100%. The clinical success rate for DEP was 96-100%.
CONCLUSIONS: Frameless stereotactic targeting devices may reach targeting errors and clinical results comparable with standard frame-based stereotaxy. Advantages and disadvantages of different devices should be acknowledged to ensure optimal technical performance.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22076960     DOI: 10.1002/rcs.441

Source DB:  PubMed          Journal:  Int J Med Robot        ISSN: 1478-5951            Impact factor:   2.547


  14 in total

1.  [Brain metastasis versus radiation necrosis after head and neck cancer : Brain lesion after head and neck cancer].

Authors:  B Kofler; J Kerschbaumer; V H Schartinger; A Posch; E R Gizewski; G Widmann
Journal:  Radiologe       Date:  2017-05       Impact factor: 0.635

Review 2.  Recent technological advances in pediatric brain tumor surgery.

Authors:  Bassel Zebian; Francesco Vergani; José Pedro Lavrador; Soumya Mukherjee; William John Kitchen; Vita Stagno; Christos Chamilos; Benedetta Pettorini; Conor Mallucci
Journal:  CNS Oncol       Date:  2016-12-21

3.  Robotic-assisted thermal ablation of liver tumours.

Authors:  Basri Johan Jeet Abdullah; Chai Hong Yeong; Khean Lee Goh; Boon Koon Yoong; Gwo Fuang Ho; Carolyn Chue Wai Yim; Anjali Kulkarni
Journal:  Eur Radiol       Date:  2014-09-05       Impact factor: 5.315

4.  Frameless robot-assisted stereotactic biopsies for lesions of the brainstem-a series of 103 consecutive biopsies.

Authors:  Iulia Peciu-Florianu; Victor Legrand; Apolline Monfilliette-Djelad; Claude-Alain Maurage; Quentin Vannod-Michel; Serge Blond; Gustavo Touzet; Nicolas Reyns
Journal:  J Neurooncol       Date:  2022-01-27       Impact factor: 4.130

Review 5.  Neuronavigation in the surgical management of brain tumors: current and future trends.

Authors:  Daniel A Orringer; Alexandra Golby; Ferenc Jolesz
Journal:  Expert Rev Med Devices       Date:  2012-09       Impact factor: 3.166

Review 6.  Stereoelectroencephalography: Indication and Efficacy.

Authors:  Koji Iida; Hiroshi Otsubo
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-06-20       Impact factor: 1.742

7.  Frameless Stereotactic Insertion of Viewsite Brain Access System with Microscope-Mounted Tracking Device for Resection of Deep Brain Lesions: Technical Report.

Authors:  Tim White; Shamik Chakraborty; Rohan Lall; Andrew A Fanous; John Boockvar; David J Langer
Journal:  Cureus       Date:  2017-02-04

8.  Technical accuracy of optical and the electromagnetic tracking systems.

Authors:  Tapani Koivukangas; Jani Pa Katisko; John P Koivukangas
Journal:  Springerplus       Date:  2013-03-08

9.  A framework for correcting brain retraction based on an eXtended Finite Element Method using a laser range scanner.

Authors:  Ping Li; Weiwei Wang; Zhijian Song; Yong An; Chenxi Zhang
Journal:  Int J Comput Assist Radiol Surg       Date:  2013-11-30       Impact factor: 2.924

10.  Stereotactic Neuro-Navigation Phantom Designs: A Systematic Review.

Authors:  Marko Švaco; Ivan Stiperski; Domagoj Dlaka; Filip Šuligoj; Bojan Jerbić; Darko Chudy; Marina Raguž
Journal:  Front Neurorobot       Date:  2020-10-23       Impact factor: 2.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.